-S Fukushima Researcher Activity Profile

Research Author Detailed Information 

S Fukushima Publication Rate By Year

S Fukushima has published 1 paper(s) in 1977, 1 paper(s) in 1982, 1 paper(s) in 1996, 2 paper(s) in 2001, 4 paper(s) in 2003, 2 paper(s) in 2004, 2 paper(s) in 2005, 4 paper(s) in 2006, 25 paper(s) in 2007, 4 paper(s) in 2008, for a total of 46 research publications in total.

S S Fukushima Author Information

LAST NAME: fukushima

FIRST NAME: S

INITIALS: s

AFFILIATION:

Papers

S Fukushima's Publication Record

1. A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration. Year Published: 2001
Novel Pharmaceutical Laboratories, Institute for Drug Development and Research, Yamanouchi Pharmaceutical Co., Ltd. 180 Ozumi, Yaizu-shi, Shizuoka-ken 425-0072, Japan. yokota_s@yamanouchi.co.jp
2. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. Year Published: 2001
Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan. suga.kazutaka@yamanouchi.co.jp
3. Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier. Year Published: 2003
Institute for Drug Development and Research, Yamanouchi Pharmaceutical Co, Ltd, 180 Ozumi, Yaizu-shi, Shizuoka 425-0072, Japan. yokota_s@yamanouchi.co.jp
4. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Year Published: 2003
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki, Japan. kokubo@yamanouchi.co.jp
5. Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. Year Published: 2003
Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan. suga.kazutaka@yamanouchi.co.jp
6. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. Year Published: 2004
Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan. suga.kazutaka@yamanouchi.co.jp
7. Material analysis end-station of the Hyogo-ken beamline at SPring-8. Year Published: 2004
Hyogo Prefectural Institute of Industrial Research, Kobe 654, Japan.
8. Current and emerging challenges in toxicopathology: Carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens. Year Published: 2005
First Department of Pathology, Osaka City University Medical School, Abeno-ku, Asahi-machi 1-4-3, Osaka 545-8585, Japan.
9. X-ray absorption fine structure combined with x-ray fluorescence spectrometry. Part 15. Monitoring of vanadium site transformations on titania and in mesoporous titania by selective detection of the vanadium K alpha1 fluorescence. Year Published: 2006
Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology, Nagatsuta 4259-G1-16, Midori-ku, Yokohama 226-8502, Japan. yizumi@chemenv.titech.ac.jp
10. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation. Year Published: 2006
Pharmacology Laboratories, Institute for Drug Discovery Research, Astellas Pharma, Inc. 21, Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan. akiyoshi.someya@jp.astellas.com
11. UDP-glucuronosyltransferase1A1 directly binds to albumin. Year Published: 2006
Faculty of Science and Technology, Department of Applied Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
12. The effect of core framework designs on the fracture loads of all-ceramic fixed partial dentures on posterior implants. Year Published: 2007
Department of Fixed Prosthodontics, Tsurumi University School of Dental Medicine, Yokohama, Japan. kokubo-y@tsurumi-u.ac.jp
13. A huge pseudoaneurysm of the left ventricle after simple gluing of an oozing-type postinfarction rupture. Year Published: 2007
Department of Cardiovascular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan.
14. pH-Responsive Multi-PEGylated Dual Cationic Nanoparticles Enable Charge Modulations for Safe Gene Delivery. Year Published: 2007
Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705-2222, USA, Fax: (+1) 608-262-5345.
15. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Year Published: 2007
Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Japan.
16. Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice. Year Published: 2007
Japan Bioassay Research Center, Japan Industrial Safety and Health Association, Hadano, Kanagawa, Japan.
17. Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans. Year Published: 2007
Department of Pharmacy, Heilongjiang Provincial Second Hospital, 159 Diduan Street, Harbin, Heilongjiang 150010, China.
18. Cell density-dependent regulation of tumor necrosis factor alpha gene expression in a human hepatoma cell line. Year Published: 2007
Department of Gene Research, The Cancer Institute (JFCR), Koto-ku, Tokyo 135-8550, Japan.
19. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Year Published: 2007
Department of Immunogenetics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan. senjusat@gpo.kumamoto-u.ac.jp
20. Reassessment of the in vivo functions of DNA polymerase I and RNase H in bacterial cell growth. Year Published: 2007
Department of Bioscience, Tokyo University of Agriculture, Sakuragaoka 1-1-1 Setagaya-ku, Tokyo 156-8502, Japan.
21. Isolation and partial characterization of the serum low density lipoprotein from bullfrog, Rana catesbeiana. Year Published: 1977
22. Cell density-dependent regulation of tumor necrosis factor alpha gene expression in a human hepatoma cell line. Year Published: 2007
Department of Gene Research, The Cancer Institute (JFCR), Tokyo, Japan.
23. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Year Published: 2007
Department of Pathology, Osaka City University Medical School, Osaka, Japan.
24. Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors. Year Published: 2007
Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan.
25. A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. Year Published: 2007
European Molecular Biology Laboratory (EMBL), Mouse Biology Unit, Campus Buzzatti-Traverso, Monterotondo-Scalo, 00016 Rome, Italy.
26. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion. Year Published: 2007
Department of Pathology, Keio University School of Medicine, Tokyo, Japan; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan; Department of Medicine, Division Hematology/Oncology, University of Pennsylvania, Philadelphia, Pa., USA
27. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Year Published: 2007
Department of Immunogenetics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan. senjusat@gpo.kumamoto-u.ac.jp
28. Reassessment of the in vivo functions of DNA polymerase I and RNase H in bacterial cell growth. Year Published: 2007
Department of Bioscience, Tokyo University of Agriculture, Sakuragaoka 1-1-1 Setagaya-ku, Tokyo 156-8502, Japan.
29. Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans. Year Published: 2007
Department of Pharmacy, Heilongjiang Provincial Second Hospital, 159 Diduan Street, Harbin, Heilongjiang 150010, China.
30. Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol. Year Published: 2006
Department of Pathology, Osaka City University Medical School, Osaka, 545-8585, Japan. wani@med.osaka-cu.ac.jp
31. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Year Published: 2007
Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Japan.
32. Selection principle for various modes of spatially nonuniform electrochemical oscillations. Year Published: 2008
Division of Chemistry, Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan.
33. Cell density-dependent regulation of tumor necrosis factor alpha gene expression in a human hepatoma cell line. Year Published: 2007
Department of Gene Research, The Cancer Institute (JFCR), Tokyo, Japan.
34. PEGylated polyplex micelles from triblock catiomers with spatially ordered layering of condensed pDNA and buffering units for enhanced intracellular gene delivery. Year Published: 2005
Department of Materials Science and Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
35. Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cells. Year Published: 2008
Department of Neurosurgery, Kurume University, School of Medicine, Kurume, Japan.
36. The effect of core framework designs on the fracture loads of all-ceramic fixed partial dentures on posterior implants. Year Published: 2007
Department of Fixed Prosthodontics, Tsurumi University School of Dental Medicine, Yokohama, Japan. kokubo-y@tsurumi-u.ac.jp
37. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Year Published: 2007
Department of Pathology, Osaka City University Medical School, Osaka, Japan.
38. Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors. Year Published: 2007
Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan. mizuhiko@med.kurume-u.ac.jp
39. A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. Year Published: 2007
European Molecular Biology Laboratory (EMBL), Mouse Biology Unit, Campus Buzzatti-Traverso, Monterotondo-Scalo, 00016 Rome, Italy.
40. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion. Year Published: 2007
Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
41. 4 x 1204 holographic switching with an optically addressed spatial light modulator. Year Published: 2008
42. The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay. Year Published: 2008
Hita laboratory, Chemicals Evaluation and Research Institute, 3-822 Ishii-machi, Hita City, Oita 877-0061, Japan.
43. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Year Published: 2007
Harefield Heart Science Centre, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, UK.
44. Radiation therapy for carcinoma of the prostate. Year Published: 1982
45. Reconstruction of a defect of the rotator cuff with polytetrafluoroethylene felt graft. Recovery of tensile strength and histocompatibility in an animal model. Year Published: 2003
Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Japan.
46. Transfer of latissimus dorsi for irreparable rotator-cuff tears. Year Published: 1996
Department of Physical Therapy, School of Health Science Sapporo Medical University, Japan.